GUTS
NASD Fractyl Health, Inc.$0.4800 ↓ -0.0645 (-11.84%) Trading Down from the previous close of $0.5444, $0.0343 below the day’s high of $0.5142
- YTD change
- -78.18%
- vs 20-day SMA
- -18.17%
- vs 200-day SMA
- -44.75%
Price ranges
Price & Performance
+0.08 (+17.15%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 96.7% away from all-time highs of $14.5000
- GUTS is down 78% since the beginning of the year
- GUTS is down 67% over the past 12 months
- GUTS is down 32% over the past 1 month
- 2% of all GUTS investors are betting against GUTS
GUTS reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -63.0%.
- Previous minute
- +$0.0038
- Last hour
- -$0.0452
- Last 5 days
- -1.16%
- vs 8-day SMA
- -6.38%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.